LearnOutLoud.com Audio - Cancer Conference Update Podcast

Optimizing the Management of Tenosynovial Giant Cell Tumor (Wed, Nov 20, 2024)
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer (Wed, Nov 20, 2024)
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (Wed, Nov 20, 2024)
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities (Mon, Nov 18, 2024)
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer (Fri, Nov 15, 2024)
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer (Fri, Nov 15, 2024)
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma (Fri, Nov 08, 2024)
Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences (Wed, Nov 06, 2024)
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review (Tue, Nov 05, 2024)
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer (Fri, Nov 01, 2024)
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma (Tue, Oct 29, 2024)
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Fri, Oct 25, 2024)
Practical Perspectives: Current Management of Chronic Myeloid Leukemia (Wed, Oct 23, 2024)
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review (Tue, Oct 22, 2024)
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors (Fri, Oct 18, 2024)
Peripheral T-Cell Lymphoma (Wed, Oct 16, 2024)
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer (Tue, Oct 15, 2024)
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series (Thu, Oct 10, 2024)
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR (Tue, Oct 08, 2024)
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations (Tue, Oct 01, 2024)
Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Tue, Sep 24, 2024)
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers (Fri, Sep 20, 2024)
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors (Tue, Sep 17, 2024)
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers (Wed, Sep 11, 2024)
Optimizing the Management of Dedifferentiated Liposarcoma (Mon, Sep 09, 2024)
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer (Fri, Sep 06, 2024)
Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation (Wed, Sep 04, 2024)
Management of Metastatic Urothelial Bladder Cancer (Fri, Aug 30, 2024)
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (Wed, Aug 28, 2024)
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer (Fri, Aug 23, 2024)
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer (Wed, Aug 21, 2024)
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer (Tue, Aug 20, 2024)
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer (Fri, Aug 16, 2024)
Novel Agents and Strategies in Lung Cancer (Tue, Aug 13, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma (Fri, Aug 09, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers (Thu, Aug 08, 2024)
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer (Tue, Aug 06, 2024)
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer (Fri, Aug 02, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer (Tue, Jul 30, 2024)
Optimizing the Identification of HER2-Low Breast Cancer (Tue, Jul 30, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology (Fri, Jul 26, 2024)
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation (Wed, Jul 24, 2024)
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review (Fri, Jul 19, 2024)
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review (Wed, Jul 17, 2024)
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer (Fri, Jul 12, 2024)
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma (Fri, Jul 12, 2024)
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer (Wed, Jul 10, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis (Mon, Jul 01, 2024)
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer (Mon, Jun 17, 2024)
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer (Wed, Jun 12, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer (Tue, Jun 11, 2024)
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer (Fri, Jun 07, 2024)
Key Presentations on Lymphoma from Recent Major Conferences (Tue, May 28, 2024)
Bispecific Antibodies in the Management of Multiple Myeloma (Fri, May 24, 2024)
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Fri, May 24, 2024)
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer (Mon, May 20, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia (Mon, May 13, 2024)
Virtual Case Library: Metastatic Triple-Negative Breast Cancer (Wed, May 08, 2024)
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition (Mon, May 06, 2024)
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Fri, May 03, 2024)
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series (Wed, May 01, 2024)
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria (Fri, Apr 26, 2024)
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium (Wed, Apr 24, 2024)
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences (Tue, Apr 23, 2024)
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Mon, Apr 15, 2024)
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences (Fri, Apr 12, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer (Fri, Apr 05, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer (Fri, Apr 05, 2024)
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates (Wed, Apr 03, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer (Wed, Mar 27, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma (Tue, Mar 26, 2024)
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer (Mon, Mar 25, 2024)
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review (Thu, Mar 21, 2024)
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer (Tue, Mar 19, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer (Fri, Mar 15, 2024)
Virtual Case Library: Metastatic Urothelial Bladder Cancer (Wed, Mar 13, 2024)
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Mon, Mar 11, 2024)
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series (Fri, Mar 08, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers (Wed, Mar 06, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia (Mon, Feb 26, 2024)
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers (Fri, Feb 23, 2024)
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series (Fri, Feb 16, 2024)
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer (Wed, Jan 31, 2024)
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series (Tue, Jan 23, 2024)
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series (Tue, Jan 16, 2024)
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition (Tue, Dec 19, 2023)
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers (Wed, Dec 13, 2023)
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer (Fri, Dec 08, 2023)
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series (Tue, Dec 05, 2023)
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer (Wed, Nov 29, 2023)
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers (Mon, Nov 20, 2023)
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series (Tue, Nov 14, 2023)
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series (Fri, Nov 10, 2023)
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series (Wed, Nov 01, 2023)
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer (Tue, Oct 24, 2023)
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series (Fri, Oct 20, 2023)
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series (Fri, Oct 20, 2023)
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma (Wed, Oct 18, 2023)
Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences (Tue, Oct 17, 2023)
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer (Fri, Oct 13, 2023)
Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian (Thu, Oct 12, 2023)
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar (Wed, Oct 11, 2023)
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series (Mon, Oct 09, 2023)
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Fri, Oct 06, 2023)
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer (Fri, Oct 06, 2023)
Blastic Plasmacytoid Dendritic Cell Neoplasm (Wed, Oct 04, 2023)
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Fri, Sep 29, 2023)
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma (Wed, Sep 27, 2023)
Novel Agents and Strategies in the Treatment of Ovarian Cancer (Mon, Sep 25, 2023)
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors (Fri, Sep 22, 2023)
Optimizing the Management of Metastatic Pancreatic Cancer (Fri, Sep 15, 2023)
The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Wed, Sep 13, 2023)
Meet The Professor: Optimizing the Management of Melanoma (Mon, Sep 11, 2023)
Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy (Fri, Sep 08, 2023)
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma (Tue, Sep 05, 2023)
Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer (Fri, Sep 01, 2023)
Role of BTK Inhibitors in Therapy for Mantle Cell Lymphoma (Wed, Aug 30, 2023)
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series (Tue, Aug 29, 2023)
Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences (Mon, Aug 28, 2023)
Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Fri, Aug 25, 2023)
Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Wed, Aug 23, 2023)
Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Tue, Aug 22, 2023)
Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Mon, Aug 21, 2023)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia (Fri, Aug 18, 2023)
Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers (Wed, Aug 16, 2023)
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Gastrointestinal Cancers Issue (Tue, Aug 15, 2023)
Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Fri, Aug 11, 2023)
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank (Fri, Aug 11, 2023)
Optimizing the Management of Metastatic Urothelial Bladder Cancer (Wed, Aug 09, 2023)
Special Edition — Current and Future Management of Breast Cancer (Tue, Aug 08, 2023)
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue (Thu, Aug 03, 2023)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal Cancers (Wed, Aug 02, 2023)
Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes (Wed, Aug 02, 2023)
Immune Thrombocytopenia Edition with Dr Hanny Al-Samkari (Fri, Jul 28, 2023)
Paroxysmal Nocturnal Hemoglobinuria Edition with Dr Carlos de Castro (Tue, Jul 25, 2023)
Special Edition — Management of Hepatobiliary Cancers (Mon, Jul 24, 2023)
Special Edition — Management of Urothelial Bladder Cancer (Fri, Jul 21, 2023)
Special Edition — Current and Future Management of Breast Cancer (Fri, Jul 21, 2023)
Special Nursing Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder Cancer (Thu, Jul 20, 2023)
The Implications of New Research Findings for the Management of Endometrial Cancer (Fri, Jul 14, 2023)
Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma (Thu, Jul 06, 2023)
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2 - Part Series (Fri, Jun 16, 2023)
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition (Wed, Apr 19, 2023)
Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition (Wed, Apr 12, 2023)
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning (Thu, Mar 02, 2023)
Management of Desmoid Tumors with Dr Mrinal Gounder (Tue, Feb 28, 2023)
Management of HER2-Altered Non-Small Cell Lung Cancer (Tue, Feb 21, 2023)
Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Mon, Feb 13, 2023)
Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting — With Dr Srdan Verstovsek (Thu, Feb 09, 2023)
Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles (Mon, Feb 06, 2023)
Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone (Thu, Feb 02, 2023)
Special Edition — Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan (Tue, Jan 31, 2023)
HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano (Thu, Jan 26, 2023)
Management of Gastroesophageal Cancers with Dr Manish Shah (Thu, Jan 12, 2023)
Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa (Thu, Jan 05, 2023)
Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog (Wed, Dec 21, 2022)
Novel Immunotherapeutic Strategies in Melanoma with Dr Omid Hamid (Tue, Dec 13, 2022)
Thyroid Cancer with Dr Eric Sherman (Thu, Dec 08, 2022)
Amyloid Light Chain (AL) Amyloidosis with Dr Jeffrey Zonder (Tue, Dec 06, 2022)
Novel Agents and Strategies in Myelofibrosis with Dr Ruben Mesa (Thu, Dec 01, 2022)
Management of Renal Cell Carcinoma with Dr Toni Choueiri (Tue, Nov 29, 2022)
Management of Hepatocellular Carcinoma with Prof Arndt Vogel (Mon, Nov 21, 2022)
Novel Agents and Strategies in AML with Dr Eytan Stein (Thu, Nov 17, 2022)
Higher-Risk Myelodysplastic Syndromes with Dr Amy DeZern (Tue, Nov 15, 2022)
Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences — With Dr Rachna Shroff (Thu, Nov 10, 2022)
Management of MET-Altered Non-Small Cell Lung Cancer with Dr Rebecca Heist (Mon, Nov 07, 2022)
Current Management of Myelofibrosis with Dr Brady Stein (Thu, Nov 03, 2022)
Neuroendocrine Tumors with Dr Pamela Kunz (Tue, Nov 01, 2022)
BRAF-Mutant Metastatic Melanoma with Prof Axel Hauschild (Thu, Oct 27, 2022)
Management of RET Fusion-Positive Non-Small Cell Lung Cancer with Dr Justin Gainor (Tue, Oct 25, 2022)
Management of Nonmetastatic Urothelial Bladder Cancer with Prof Sia Daneshmand (Thu, Oct 20, 2022)
Management of Small Cell Lung Cancer with Dr Benjamin Levy (Thu, Oct 06, 2022)
BCMA-Directed Therapies for Multiple Myeloma with Dr Amrita Krishnan (Thu, Sep 29, 2022)
Management of Localized Non-Small Cell Lung Cancer with Dr Heather Wakelee (Mon, Sep 26, 2022)
Current and Future Management of Hodgkin Lymphoma with Dr Stephen Ansell (Thu, Sep 15, 2022)
Interstitial Lung Disease in Patients Receiving Anticancer Therapy with Dr Charles Powell (Tue, Sep 13, 2022)
Endometrial Cancer Edition with Dr Mansoor Raza Mirza (Thu, Sep 08, 2022)
Ocular Toxicities in Patients Receiving Anticancer Therapy with Dr Asim Farooq (Tue, Sep 06, 2022)
Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting with Dr Joshua Sabari (Wed, Aug 24, 2022)
KRAS-Mutant Non-Small Cell Lung Cancer (Thu, Aug 18, 2022)
Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting with Dr Brian Slomovitz (Tue, Aug 16, 2022)
Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting with Dr Ezra Cohen (Mon, Aug 08, 2022)
Recent Updates in the Management of HER2-Low Breast Cancer with Dr Shanu Modi (Tue, Aug 02, 2022)
Management of Unresectable Stage III Non-Small Cell Lung Cancer with Drs Jeffrey Bradley and David Spigel (Mon, Aug 01, 2022)
Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting with Dr Sandy Srinivas (Thu, Jul 28, 2022)
Management of Cholangiocarcinoma and Other Biliary Tract Cancers with Professor Juan Valle (Thu, Jul 21, 2022)
Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting with Dr Angela DeMichele (Mon, Jul 18, 2022)
Recent Updates in HER2-Low Breast Cancer with Dr Adam Brufsky (Thu, Jul 07, 2022)
Current and Future Management of Follicular Lymphoma with Dr Loretta Nastoupil (Tue, Jul 05, 2022)
Updates on Ovarian Cancer from SGO 2022 with Dr David O’Malley (Wed, May 04, 2022)
PARP Inhibitors in Breast Cancer with Dr Judy Garber (Wed, Apr 20, 2022)
Advances in Soft Tissue Sarcomas with Dr Mark Agulnik (Mon, Mar 14, 2022)
Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari (Thu, Mar 10, 2022)
Key Presentations on Advances in Myeloproliferative Neoplasms from ASH 2021 with Dr Prithviraj Bose (Mon, Mar 07, 2022)
Advances in the Treatment of Hodgkin and Non-Hodgkin Lymphomas from ASH 2021 with Dr Matthew Lunning (Mon, Feb 21, 2022)
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from ASH 2021 (Thu, Feb 17, 2022)
Current Issues in the Research and Management of Localized Hormone Receptor-Positive Breast Cancer with Dr Sara Tolaney. (Fri, Feb 11, 2022)
Recent Advances in the Treatment of Chronic Lymphocytic Leukemia with Dr Peter Hillmen (Wed, Feb 09, 2022)
Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids (Wed, Feb 02, 2022)
Managing Transplant-Ineligible Newly Diagnosed Multiple Myeloma with Dr Saad Zafar Usmani (Mon, Jan 31, 2022)
Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer with Dr Evan Yu (Fri, Jan 21, 2022)
Biomarker-Directed Therapy for Colorectal Cancer with Dr Christopher Lieu (Fri, Jan 14, 2022)
PARP Inhibition in Pancreatic Cancer with Dr Michael Pishvaian (Wed, Jan 12, 2022)
Modern Management of Metastatic Castration-Resistant Prostate Cancer with Dr Alan Bryce (Mon, Jan 03, 2022)
Advances in Genetic Profiling and Targeted Therapies for Colorectal Cancer with Dr Arvind Dasari (Mon, Dec 20, 2021)
Ovarian Cancer with Dr Bradley Monk (Fri, Dec 17, 2021)
NSCLC with EGFR Exon 20 Insertion Mutations with Dr Gregory Riely (Fri, Dec 17, 2021)
Novel Immunotherapeutic Strategies in Melanoma with Dr Adil Daud (Mon, Dec 13, 2021)
Optimal Management of Hodgkin Lymphoma in Younger and Older Patients with Dr Neil Love (Thu, Dec 09, 2021)
Advances in Endometrial Cancer with Dr Matthew Powell (Wed, Dec 08, 2021)
Chronic Lymphocytic Leukemia with Professor Dr Arnon Kater (Mon, Nov 22, 2021)
Myelodysplastic Syndromes with Dr Michael Savona (Mon, Nov 15, 2021)
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen (Mon, Nov 08, 2021)
Head and Neck Cancer with Dr Cristina Rodriguez (Fri, Nov 05, 2021)
Myeloproliferative Neoplasms with Dr Ruben Mesa (Mon, Nov 01, 2021)
Chronic Myeloid Leukemia with Dr Michael Mauro (Tue, Oct 26, 2021)
Renal Cell Carcinoma with Dr Sumanta Pal (Fri, Oct 08, 2021)
Thyroid Cancer with Dr Marcia Brose (Mon, Oct 04, 2021)
Gastroesophageal Cancers with Dr Samuel Klempner (Thu, Sep 23, 2021)
Management of HER2-Low Breast Cancer with Dr Ian Krop (Thu, Sep 23, 2021)
Key Presentations on Gynecologic Cancers from the 2021 ASCO Annual Meeting with Dr Kathleen Moore (Thu, Sep 02, 2021)
Thyroid Cancer with Dr Lori Wirth (Thu, Aug 19, 2021)
Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting with Dr Joel Neal (Tue, Aug 10, 2021)
CAR T-Cell Therapy in Multiple Myeloma with Dr Jesús Berdeja (Thu, Aug 05, 2021)
Key Presentations on Gastrointestinal Cancers from the 2021 ASCO Annual Meeting with Dr Kristen Ciombor (Fri, Jul 30, 2021)
Key Presentations on Breast Cancer from the 2021 ASCO Annual Meeting with Dr Sara Tolaney (Fri, Jul 23, 2021)
Gastroesophageal Cancers with Dr Jaffer Ajani (Thu, Jul 22, 2021)
Key Presentations on Genitourinary Cancers from the 2021 ASCO Annual Meeting with Dr Arjun Balar (Thu, Jul 15, 2021)
Progress in Myelodysplastic Syndromes with Dr Guillermo Garcia-Manero (Tue, Jul 13, 2021)
HER2-Positive Localized Breast Cancer with Dr Adam Brufsky (Tue, May 11, 2021)
Genomic Assays in Early Breast Cancer (Thu, May 06, 2021)
Advances in the Management of Amyloid Light Chain Amyloidosis with Dr Morie Gertz (Fri, Apr 30, 2021)
Advances in the Management of Cholangiocarcinoma with Dr Mitesh Borad (Thu, Apr 29, 2021)
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst (Mon, Apr 12, 2021)
Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting with Dr Laurie Sehn (Wed, Apr 07, 2021)
Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander (Fri, Apr 02, 2021)
Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli (Mon, Mar 29, 2021)
Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba (Fri, Mar 26, 2021)
Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia (Tue, Mar 23, 2021)
Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles (Mon, Mar 22, 2021)
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei (Fri, Mar 19, 2021)
PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín (Fri, Mar 12, 2021)
Predictors of Response to Cancer Immunotherapy with Prof Solange Peters (Fri, Mar 12, 2021)
Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael (Wed, Mar 10, 2021)
Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska (Mon, Mar 08, 2021)
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram (Wed, Mar 03, 2021)
Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson (Mon, Mar 01, 2021)
New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor (Fri, Feb 26, 2021)
ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton (Wed, Feb 24, 2021)
Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce (Fri, Feb 19, 2021)
Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore (Fri, Feb 19, 2021)
Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre (Tue, Feb 16, 2021)
Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds (Fri, Feb 12, 2021)
Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky (Fri, Feb 05, 2021)
Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer (Fri, Jan 29, 2021)
The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Shannon Westin (Tue, Jan 19, 2021)
Key Presentations on the Treatment of Multiple Myeloma from the 2020 ASH Annual Meeting with Dr Sagar Lonial (Fri, Jan 15, 2021)
Current Challenges of COVID-19 in Southern California with Dr David Quinn (Fri, Jan 08, 2021)
Current Management of and Future Directions in Mesothelioma with Dr Marjorie Zauderer (Wed, Dec 30, 2020)
The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer with Dr Stephen Liu (Tue, Dec 22, 2020)
The Role of PARP Inhibition in the Management of Ovarian Cancer with Dr Ursula Matulonis (Mon, Dec 21, 2020)
The Role of PARP Inhibition in the Management of Breast Cancer with Dr Hope Rugo (Mon, Dec 21, 2020)
The Role of PARP Inhibition in the Management of Pancreatic Cancer with Dr Philip A Philip (Mon, Dec 21, 2020)
The Role of PARP Inhibition in the Management of Prostate Cancer with Dr Maha Hussain (Mon, Dec 21, 2020)
Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma with Dr Joaquim Bellmunt (Tue, Dec 15, 2020)
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers with Dr David O'Malley (Thu, Dec 10, 2020)
Management of Pancreatic Cancer with Dr Andrew Ko (Wed, Dec 09, 2020)
Key Recent Data Sets in Gastrointestinal Cancers with Dr Philip A Philip (Mon, Dec 07, 2020)
Immune Checkpoint Inhibition in Breast Cancer with Dr Sylvia Adams (Mon, Dec 07, 2020)
The Role of Liquid Biopsy for Cancer Screening with Dr Eric Klein (Wed, Dec 02, 2020)
Novel Agents Under Investigation in Multiple Myeloma with Dr Peter Voorhees (Tue, Dec 01, 2020)
Adjuvant Therapy for ER-Positive Breast Cancer with Prof Stephen Johnston (Thu, Nov 19, 2020)
Management of Non-Small Cell Lung Cancer with ALK and ROS1 Rearrangements with Dr Ross Camidge (Wed, Nov 18, 2020)
Management of Gastroesophageal Cancers with Dr Daniel Catenacci (Mon, Nov 16, 2020)
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat (Thu, Nov 05, 2020)
Renal Cell Carcinoma (Wed, Nov 04, 2020)
Acute Myeloid Leukemia with FLT3 Mutations (Fri, Oct 30, 2020)
Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma (Tue, Oct 27, 2020)
PARP Inhibition in the Management of Pancreatic Cancer (Fri, Oct 23, 2020)
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy (Wed, Oct 21, 2020)
Front-Line Treatment of Chronic Lymphocytic Leukemia (Tue, Oct 13, 2020)
Hodgkin Lymphoma (Fri, Oct 02, 2020)
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition (Wed, Sep 30, 2020)
PARP Inhibitors in Breast Cancer Edition (Wed, Sep 23, 2020)
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition (Mon, Sep 21, 2020)
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition (Thu, Sep 17, 2020)
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition (Tue, Sep 15, 2020)
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition (Fri, Sep 11, 2020)
Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition (Fri, Sep 04, 2020)
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition (Fri, Aug 28, 2020)
Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard (Tue, Aug 18, 2020)
Oncology Today Special Roundtable: Colorectal Cancer (Wed, Aug 05, 2020)
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson (Sat, Aug 01, 2020)
Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer (Tue, Jun 16, 2020)
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2 (Fri, Jun 05, 2020)
Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19 (Wed, May 27, 2020)
Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era (Tue, May 19, 2020)
Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic (Fri, May 15, 2020)
Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic (Sun, May 03, 2020)
AACR Virtual Spectacular: Dr Leora Horn Comments on the New COVID-19 Lung Cancer Registry (Wed, Apr 29, 2020)
Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber (Fri, Apr 24, 2020)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle (Tue, Apr 21, 2020)
COVID-19 and Prostate Cancer (Thu, Apr 09, 2020)